Sester DP, Brion K, Trieu A, Goodridge HS, Roberts TL, Dunn J, et al
Weight-loss drugs that mimic glucagon-like peptide-1 (GLP-1) may help prevent further tissue damage after a heart attack, significantly lowering the risk of life-threatening complications that affect up to half of patients, according to a new study led by researchers at the University of Bristol and University College London (UCL)
Inflammation Reduction : His studies indicate that GLP-1 can reduce systemic inflammation, a key factor in aging and the development of chronic diseases
It is taken a short while after the last meal, once the stomach is empty
Vulnerability to extra stress may last somewhat longer and a severe stress may temporarily bring back some symptoms
Patient preference, taken seriously but not in isolation